COLLECTING GAIT INFORMATION FOR EVALUATION AND CONTROL OF THERAPY

• US 20140249600A1
• Filed: 05/15/2014
• Published: 09/04/2014
• Est. Priority Date: 03/24/2006
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Heruth, Kenneth T., Miesel, Keith A., Molnar, Gregory F.
• Granted Patent: US 9,592,379 B2
• Time in Patent Office: Days
• US Class Current: 607/49
• CPC Class Codes: A61B 2562/0219 Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
• CPC Class Codes: A61B 5/0022 Monitoring a patient using a global network, e.g. telephone networks, internet
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/031 Intracranial pressure
• CPC Class Codes: A61B 5/1038 Measuring plantar pressure during gait
• CPC Class Codes: A61B 5/112 Gait analysis
• CPC Class Codes: A61B 5/1123 Discriminating type of movement, e.g. walking or running A61B5/1116, A61B5/112 take precedence
• CPC Class Codes: A61B 5/389 Electromyography [EMG]
• CPC Class Codes: A61B 5/4082 Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
• CPC Class Codes: A61B 5/4094 Diagnosing or monitoring seizure diseases, e.g. epilepsy
• CPC Class Codes: A61B 5/4836 Diagnosis combined with treatment in closed-loop systems or methods A61B5/0036 takes precedence
• CPC Class Codes: A61B 5/7246 using correlation, e.g. template matching or determination of similarity
• CPC Class Codes: A61B 5/7275 Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• CPC Class Codes: A61B 5/7282 Event detection, e.g. detecting unique waveforms indicative of a medical condition A61B5/4094, A61B5/4818, A61B5/349, A61B5/0823 take precedence
• CPC Class Codes: A61B 5/7405 using sound
• CPC Class Codes: A61B 5/742 using visual displays A61B5/339 takes precedence
• CPC Class Codes: A61B 5/7455 characterised by tactile indication, e.g. vibration or electrical stimulation
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: A61N 1/36003 of motor muscles, e.g. for walking assistance
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36082 : Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/3615 : Intensity
• CPC Class Codes: G16Z 99/00 : Subject matter not provided for in other main groups of this subclass

Abstract

A medical device delivers a therapy to a patient. The medical device or another device may periodically determine an activity level or gait parameter of the patient, and associate each determined level or parameter with a current therapy parameter set. A value of at least one activity metric is determined for each of a plurality of therapy parameter sets based on the activity levels or parameters associated with that therapy parameter set. Whether the patient is currently experiencing or anticipated to experience gait freeze caused by their neurological disorder, such as Parkinson'"'"'s disease, may also be determined. Gait freeze events may be associated with current therapy parameters and used to determine activity metric values. In some examples, the activity metric associated with certain therapy parameters may be presented to a user.

Claims

1. A method comprising:

monitoring, with an implantable medical device, a physiological signal of a patient based on a signal generated by an implantable sensor within the patient;

predicting, with the implantable medical device, a gait freeze event based on the signal; and

providing stimulation therapy to the patient from the implantable medical device in response to the predicted gait freeze event to mitigate the gait freeze event.

2. The method of claim 1, wherein predicting, with the implantable medical device, the gait freeze event based on the signal includes predicting the gate freeze event prior to onset of the gate freeze event.

3. The method of claim 1,

wherein the signal generated by the implantable sensor includes an electromyogram (EMG) signal, and

wherein predicting, with the implantable medical device, the gait freeze event based on the signal includes predicting the gate freeze event based on irregular EMG activity in the EMG signal.

4. The method of claim 1,

wherein the signal generated by the implantable sensor includes an electroencephalogram (EEG) signal, and

wherein predicting, with the implantable medical device, the gait freeze event based on the signal includes predicting the gate freeze event based on irregular EEG activity in the EEG signal.

5. The method of claim 1, wherein predicting, with the implantable medical device, the gait freeze event based on the signal includes:

monitoring a gait of the patient based on the signal generated by the implantable sensor; and

anticipating, with the implantable medical device, the gait freeze event based on the signal.

6. The method of claim 1, wherein predicting, with the implantable medical device, the gait freeze event based on the signal includes:

monitoring a gait of the patient based on the signal generated by the implantable sensor; and

detecting, with the implantable medical device, the gait freeze event based on the signal.

7. The method of claim 1, wherein providing the stimulation therapy to the patient from the implantable medical device in response to the predicted gait freeze event to mitigate the gait freeze event includes delivering stimulation via one or more electrodes to the brain of the patient.

8. The method of claim 1, further comprising providing audible gate cues to the patient in response to the predicted gait freeze event to mitigate the gait freeze event.

9. The method of claim 1, wherein providing the stimulation therapy to the patient from the implantable medical device in response to the predicted gait freeze event to mitigate the gait freeze event includes delivering rhythmic electrical stimulation perceivable by the patient.

10. The method of claim 1, wherein monitoring the physiological signal of the patient includes monitoring the physiological signal of the patient with one or more electrodes of the implantable sensor.

11. The method of claim 1, wherein monitoring the physiological signal of the patient includes sensing activity via an activity sensor.

12. The method of claim 1, wherein providing the stimulation therapy to the patient from the implantable medical device in response to the predicted gait freeze event to mitigate the gait freeze event includes modifying at least one of a movement disorder therapy, Parkinson'"'"'s disease therapy, epilepsy therapy, tremor therapy, or deep brain stimulation being delivered to the patient.

13. A system comprising:

an implantable sensor configured to generate a signal that varies as a function of activity of a patient;

a processor configured to monitor a physiological signal of a patient based on the signal generated by the implantable sensor and predicts a gait freeze event based on the signal; and

an implantable medical device configured to provide stimulation therapy to the patient in response to the predicted gait freeze event to mitigate the gait freeze event.

14. The system of claim 13, wherein the processor is configured to predict the gait freeze event based on the signal prior to onset of the gate freeze event.

15. The system of claim 13,

wherein the signal generated by the implantable sensor includes an electromyogram (EMG) signal, and

wherein the processor is configured to predict the gait freeze event based on irregular EMG activity in the EMG signal.

16. The system of claim 13,

wherein the signal generated by the implantable sensor includes an electroencephalogram (EEG) signal, and

wherein the processor is configured to predict the gait freeze event based on irregular EEG activity in the EEG signal.

17. The system of claim 13, wherein the implantable medical device is configured to deliver rhythmic electrical stimulation perceivable by the patient in response to the predicted gait freeze event to mitigate the gait freeze event.

18. The system of claim 13, wherein the implantable medical device is configured to modify at least one of a movement disorder therapy, Parkinson'"'"'s disease therapy, epilepsy therapy, tremor therapy, or deep brain stimulation being delivered to the patient in response to the predicted gait freeze event to mitigate the gait freeze event.

19. A non-transitory computer-readable storage medium comprising instructions that cause a processor to:

monitor a physiological signal of a patient based on a signal generated by an implantable sensor within the patient;

predict a gait freeze event based on the signal; and

issue instructions to an implantable medical device to provide stimulation therapy to the patient from the implantable medical device in response to the predicted gait freeze event to mitigate the gait freeze event.

20. The non-transitory computer-readable storage medium of claim 19, wherein the instructions to the implantable medical device to provide stimulation therapy to the patient from the implantable medical device in response to the predicted gait freeze event to mitigate the gait freeze event include instructions to deliver rhythmic electrical stimulation perceivable by the patient.

21. The non-transitory computer-readable storage medium of claim 19, wherein the instructions to the implantable medical device to provide stimulation therapy to the patient from the implantable medical device in response to the predicted gait freeze event to mitigate the gait freeze event include instructions to modify at least one of a movement disorder therapy, Parkinson'"'"'s disease therapy, epilepsy therapy, tremor therapy, or deep brain stimulation being delivered to the patient.